Type II Diabetes MellitusNCT07107620
Dual Task Performance and Type II Diabetes Mellitus
An observational study of Type II Diabetes Mellitus and Dual Task Cost, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to compare the dual task performances of individuals with and without type 2 diabetes. Thus, it will be concluded whether having type 2 diabetes affects dual task performance. Read more about this study
- Who is it for?
- Ages 50 years and olderHealthy volunteers can take part
- Conditions the study is for
- Type II Diabetes Mellitus, Dual Task Cost
- What is being tested?
- one task and dual task
- How many people
- 141 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2022to 1 Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Individuals who have had diabetes for at least 1 year and are over 50 years of age and their matched healthy controls constitute the study sample.
Who may be able to join
- Having been diagnosed with Type II DM (for the Type II diabetes group)
- Being 50 years old or older
- Being a native Turkish speaker
Who cannot join
- Not being able to read and write,
- Having communication problems,
- Having a score below 24 points on the Standardized Mini-Mental Test,
- Having one of the neurological diseases that will affect the study such as Parkinson's, stroke, etc.,
- Having upper and/or lower extremity surgery in the last year or having a surgical history that will affect walking,
- Having retinopathy, foot ulcers, and severe sensory impairment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Investigation of Dual Task Performance of Individuals With Type 2 Diabetes Mellitus
The aim of this study is to compare the dual task performances of individuals with and without type 2 diabetes. Thus, it will be concluded whether having type 2 diabetes affects dual task performance.
Read the detailed description
In our daily lives, we often have to juggle many tasks simultaneously. Performing two tasks simultaneously is called dual-tasking. The ability to perform two tasks simultaneously is called dual-tasking performance. Dual-tasking performance can decrease in individuals with diabetes due to complications of diabetes. This study compared the dual-tasking performance of individuals with type 2 diabetes and healthy individuals using dual-tasking tests categorized as easy, medium, and difficult.
- Conditions
- Type II Diabetes Mellitus, Dual Task Cost
- Being tested
- one task, dual task
- Keywords
- Type II Diabetes Mellitus, Dual-task, Cognition
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
one taskDiagnostic test
Single task tests consist of measuring walking times with normal walking (easy), walking with a 50% reduction in the base of support measured between the medial malleoli (medium difficulty) and tandem walking (difficult) tasks while applying the 10 meter walk test and time up go tests.
dual taskDiagnostic test
Dual task consists of single task plus tests of carrying glasses of water or counting backwards from a given number.
| Study group | Role | What they receive |
|---|---|---|
| type II diabetes mellitus group | Dual task tests were applied to the group with type 2 diabetes mellitus Receives: Diagnostic Test: one task; Diagnostic Test: dual task | |
| Healthy group | Dual task tests were administered to the healthy group Receives: Diagnostic Test: one task; Diagnostic Test: dual task |
What is being measured
The primary outcome is the main question the study is designed to answer.
10 meter walk test
The dual task cost was calculated to measure dual task performance by applying the 10-meter walking test as single and dual tasks.
This cost will be calculated as follows:
(Dual task performance-single task performance)/ single task performance x100
Measured: one day
time up go test
The dual task cost was calculated to measure dual task performance by applying the time up go test as single and dual tasks. This cost will be calculated as follows: (Dual task performance-single task performance)/ single task performance x100
Measured: one day
Secondary outcomes (2)
Stroop test
There are 5 sections in this test. Section 1 includes reading black text, section 2 includes reading colored words related to color names, section 3 includes saying the color of shapes, section 4 includes saying the color of words that are not color names, and section 5 includes saying the color of colored words that are color names. Individuals are asked to read from left to right as fast as possible. The time taken is recorded in seconds.
Measured: one day
Dual task survey
It is a test that questions the difficulties experienced by individuals during dual-task activities in daily life activities. The survey consists of 10 questions. The short duration of the survey is an advantage. The survey, which consists of 5 answers, is scored between 0 and 4. A score of ''4'' indicates that difficulties are experienced very often, ''0'' indicates that there is no difficulty.
Measured: one day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2025
- Study start1 Sep 2022
- Primary completion1 Mar 2023
- Study completion1 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Type II Diabetes MellitusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 141 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Abdulkadir Ertürk, Kahramanmaras Sutcu Imam University
- Investigators
- Suat EREL, professor, Study director, Pamukkale University Faculty of Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07107620
- Sponsor's protocol ID
- KSÜKADİRERTÜRK1
- Status last verified
- Jul 2025
- First submitted
- 28 Jun 2025
- Last updated
- 6 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of Dual Task Performance of Individuals With Type 2 Diabetes Mellitus
- ClinicalTrials.gov ID
- NCT07107620
- Acronym / sponsor ID
- KSÜKADİRERTÜRK1
- Conditions
- Type II Diabetes Mellitus, Dual Task Cost
- Keywords
- Type II Diabetes Mellitus, Dual-task, Cognition
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 141 participants (actual)
- Lead sponsor
- Kahramanmaras Sutcu Imam UniversityUniversity, hospital or other
- Study start
- 1 Sep 2022 (actual)
- Primary completion
- 1 Mar 2023 (actual)
- Study completion
- 1 Jun 2023 (actual)
- First posted
- 6 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to compare the dual task performances of individuals with and without type 2 diabetes. Thus, it will be concluded whether having type 2 diabetes affects dual task performance.
Detailed description
In our daily lives, we often have to juggle many tasks simultaneously. Performing two tasks simultaneously is called dual-tasking. The ability to perform two tasks simultaneously is called dual-tasking performance. Dual-tasking performance can decrease in individuals with diabetes due to complications of diabetes. This study compared the dual-tasking performance of individuals with type 2 diabetes and healthy individuals using dual-tasking tests categorized as easy, medium, and difficult.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| type II diabetes mellitus group | – | Diagnostic Test: one task, Diagnostic Test: dual taskDual task tests were applied to the group with type 2 diabetes mellitus |
| Healthy group | – | Diagnostic Test: one task, Diagnostic Test: dual taskDual task tests were administered to the healthy group |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Individuals who have had diabetes for at least 1 year and are over 50 years of age and their matched healthy controls constitute the study sample.
Key inclusion criteria (3 listed)
- Having been diagnosed with Type II DM (for the Type II diabetes group)
- Being 50 years old or older
- Being a native Turkish speaker
Key exclusion criteria (6 listed)
- Not being able to read and write,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| one taskSingle task tests consist of measuring walking times with normal walking (easy), walking with a 50% reduction in the base of support measured between the medial malleoli (medium difficulty) and tandem walking (difficult) tasks while applying the 10 meter walk test and time up go tests. | Diagnostic test | Healthy group, type II diabetes mellitus group |
| dual taskDual task consists of single task plus tests of carrying glasses of water or counting backwards from a given number. | Diagnostic test | Healthy group, type II diabetes mellitus group |
Primary outcome
10 meter walk test
Time frame: one day
The dual task cost was calculated to measure dual task performance by applying the 10-meter walking test as single and dual tasks. This cost will be calculated as follows: (Dual task performance-single task performance)/ single task performance x100
time up go test
Time frame: one day
The dual task cost was calculated to measure dual task performance by applying the time up go test as single and dual tasks. This cost will be calculated as follows: (Dual task performance-single task performance)/ single task performance x100
2 secondary outcomes
Stroop test
Time frame: one day
Dual task survey
Time frame: one day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2025.
- Individual participant dataSharing planned: No
Related trials for Type II Diabetes Mellitus
Not yet recruiting
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Active, not recruiting
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
Type 2 Diabetes Mellitus (T2DM)
Not yet recruiting
Care COMPASS Study
Diabetes Mellitus ( Type 1 and Type 2), Hypertension
Enrolling by invitationObservational study
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis
Type 2 Diabetes
RecruitingObservational study
Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
Sarcopenia, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Suat EREL, professor study director
Pamukkale University Faculty of Health Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Type II Diabetes Mellitus and Dual Task Cost, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
10 meter walk test (time frame: one day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2025.